Impact of baseline tricuspid regurgitation on long-term clinical outcomes and survival after interventional edge-to-edge repair for mitral regurgitation

Clinical Research in Cardiology

Volumn 106, Issue 5, 2017, Pages 350-358

  Schueler, Robert ^a   Öztürk, Can ^a   Sinning, Jan Malte ^a   Werner, Nikos ^a   Welz, Armin ^a   Hammerstingl, Christoph ^a   Nickenig, Georg ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Heart failure; MitraClip; Percutaneous repair; Tricuspid regurgitation

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CLINICAL OUTCOME; DISEASE SEVERITY; EUROSCORE; FEMALE; FLUOROSCOPY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION TIME; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTABLE CLIP; INFERIOR CAVA VEIN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE SURGERY; PREVALENCE; SIX MINUTE WALK TEST; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VERY ELDERLY; CAUSALITY; CLINICAL TRIAL; COMORBIDITY; DEVICES; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; GERMANY; HEART VALVE REPLACEMENT; INCIDENCE; LONGITUDINAL STUDY; MITRAL ANNULOPLASTY; MORTALITY; POSTOPERATIVE COMPLICATION; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURGICAL EQUIPMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTILIZATION;

AGED; CAUSALITY; COMORBIDITY; FEMALE; GERMANY; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL INSTRUMENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRICUSPID VALVE INSUFFICIENCY;

EID: 85006802801     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-016-1062-1     Document Type: Article

References (23)

1. Iung B (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 24:1231–1243
2. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schofers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M, Bax JJ, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496
3. Boekstegers P, Hausleiter J, Baldus S, Von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schäfer U, Schillinger W, Wunderlich N (2014) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103(2):85–96
4. Zuern CS, Bauer A, Lubos E, Boekstegers P, Puls M, Bardeleben RSV, Ouarrak T, Butter C, Eggebrecht H, Nickenig G, Zahn R, Senges J, May AE (2015) Influence of non-cardiac comorbidities on outcome after percutaneous mitral valve repair: results from the German transcatheter mitral valve interventions (TRAMI) registry. Clin Res Cardiol 104:1044–1053
5. Maisano F, Franzen O, Baldus S, Schofer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W (2013) Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, A prospective, multicenter, nonrandomized post-approval study of the Mitraclip therapy in Europe. J Am Coll Cardiol 62:1052–1061
6. Wallenborn J, Störk S, Herrmann S, Kukuy O, Fette G, Puppe F, Gorski A, Hu K, Voelker W, Ertl G, Weidemann F (2016) Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip). Clin Res Cardiol 105(8):699–709
7. Shiran A, Sagie A (2009) Tricuspid regurgitation in mitral valve disease. incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 53(5):401–408
8. Di Mauro M, Bivona A, Iacò AL, Contini M, Gagliardi M, Varone E, Gallina S, Calafiore AM (2009) Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation. Eur J Cardiothorac Surg 35:635–640
9. De Bonis M, Lapenna E, Sorrentino F, La Canna G, Grimaldi A, Maisano F, Torracca L, Alfieri O (2008) Evolution of tricuspid regurgitation after mitral valve repair for functional mitral regurgitation in dilated cardiomyopathy. Eur J Cardiothorac Surg 33:600–606
10. Sagie A, Schwammenthal E, Newell JB, Harrell L, Joziatis TB, Weyman AE, Levine RA, Palacios IF (1994) Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol 24:696–702
11. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF (2002) Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144:524–529
12. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406
13. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, Hagendorff A, Monin JL, Badano L, Zamorano JL, Sicari R, Vahanian A, Roelandt JRTC (2010) European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 14(7):611–644
14. Rodés-Cabau J, Taramasso M, O’Gara PT (2016) Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet (London, England). doi:10.1016/S0140-6736(16)00740-6
15. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol 148(1):e1–e132
16. Rogers JH, Bolling SF (2009) The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation 119(20):2718–2725
17. Ohno Y, Attizzani GF, Capodanno D, Cannata S, Dipasqua F, Imme S, Barbanti M, Ministeri M, Caggegi A, Pistritto AM, Chiaranda M, Ronsivalle G, Giaquinta S, Farruggio S, Mangiafico S, Scandura S, Tamburino C, Capranzano P, Grasso C (2014) Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. Eur Hear J Cardiovasc Imaging 15:1246–1255
18. Siegel RJ, Biner S, Rafique AM, Rinaldi M, Lim S, Fail P, Hermiller J, Smalling R, Whitlow PL, Herrmann HC, Foster E, Feldman T, Glower D, Kar S (2011) The acute hemodynamic effects of mitraclip therapy. J Am Coll Cardiol 57:1658–1665
19. Rogers JH, Franzen O (2011) Percutaneous edge-to-edge MitraClip therapy in the management of mitral regurgitation. Eur Heart J 32(19):2350–2357
20. Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT (2015) First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol 65:1190–1195
21. Malasa M, Werner N, Nickenig G, Hammerstingl C (2016) Transcatheter tricuspid valve repair in a patient with isolated functional tricuspid valve regurgitation. Eur Heart J 37:855
22. Hammerstingl C, Schueler R, Malasa M, Werner N, Nickenig G (2016) Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J 37:849–853
23. Rodés-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, Schofer J, Campelo-Parada F, Puri R, Vahanian A (2016) Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol 67(15):1829–1845